2019
DOI: 10.1002/cbic.201900508
|View full text |Cite
|
Sign up to set email alerts
|

Cell‐Wall‐Targeting Antibiotics Cause Lag‐Phase Bacteria to Form Surface‐Mediated Filaments Promoting the Formation of Biofilms and Aggregates

Abstract: Antibiotics are known to promote bacterial formation of enhanced biofilms, the mechanism of which is not well understood. Here, using biolayer interferometry, we have shown that bacterial cultures containing antibiotics that target cell walls cause biomass deposition on surfaces over time with a linear profile rather than the Langmuir‐like profiles exhibited by bacterial adherence in the absence of antibiotics. We observed about three times the initial rate and 12 times the final biomass deposition on surfaces… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 65 publications
(116 reference statements)
0
2
0
Order By: Relevance
“…The prevalence of multidrug resistant bacteria (MDR) strains is a worldwide healthcare issue and over 70% of bacterial infections are resistant to one or more of the antibiotics , that are generally used to eradicate infections. Thus, it is urgent to develop novel antibiotics to overcome the disadvantage of the conventional antibiotics. Recent advances in antimicrobial nanomaterials have made nanotechnology a powerful solution to this dilemma. Nanomaterials may become the mainstream in treating bacterial infections due to the high antibacterial efficacy and multiple antibacterial mechanisms. Among nanomaterials, gold nanoparticles (Au NPs) have high surface-to-volume ratio, precise controlled surfaces, unique optical properties, and low toxicity, making them promising candidates for developing nanoscale antibiotics.…”
mentioning
confidence: 99%
“…The prevalence of multidrug resistant bacteria (MDR) strains is a worldwide healthcare issue and over 70% of bacterial infections are resistant to one or more of the antibiotics , that are generally used to eradicate infections. Thus, it is urgent to develop novel antibiotics to overcome the disadvantage of the conventional antibiotics. Recent advances in antimicrobial nanomaterials have made nanotechnology a powerful solution to this dilemma. Nanomaterials may become the mainstream in treating bacterial infections due to the high antibacterial efficacy and multiple antibacterial mechanisms. Among nanomaterials, gold nanoparticles (Au NPs) have high surface-to-volume ratio, precise controlled surfaces, unique optical properties, and low toxicity, making them promising candidates for developing nanoscale antibiotics.…”
mentioning
confidence: 99%
“…Similarly, polyploidy facilitates DNA mutational repair by homologous recombination, or CRISP-Cas mediated adaptive immunity (Bos et al 2015, Wang et al 2019. Also, filamentation favors bacterial adhesion to biological or inert surfaces (Möller et al, 2013); perhaps, adhesion is required for effective filamentation (Jin et al, 2020), including microbiotic particles where different organisms coalesce (Baquero et al, 2022), where nutrients also accumulate. On surfaces, filamentation facilitates biofilm formation (Anbumani et al, 2021;Yoon et al, 2011), and probably functions associated with quorum sensing (Chuang et al, 2019).…”
Section: Environmental Stress and Cellular Differentiation In Bacteriamentioning
confidence: 99%